Title:
COMPOSITION COMPRISING RAAV CONTAINING SOLUBLE VEGFR-1 DERIVATIVE CDNA FOR TREATMENT OF MACULAR DEGENERATION
Document Type and Number:
WIPO Patent Application WO/2019/083171
Kind Code:
A2
Abstract:
The present invention relates to a pharmaceutical composition for treatment or prevention of macular degeneration and, more particularly, to a recombinant vector carrying a soluble VEGF receptor derivative cDNA and a pharmaceutical composition comprising the same for treatment or prevention of macular degeneration. According to the present invention, age-related macular degeneration, which is a representative retinal disease causing blindness in adults, can be effectively treated and a prophylactic effect can be expected.
Inventors:
LEE YOUNG-ILL (KR)
LEE HYUN SEUNG (KR)
KIM YERYANG (KR)
SHIN HYE JUNG (KR)
LEE HYUN SEUNG (KR)
KIM YERYANG (KR)
SHIN HYE JUNG (KR)
Application Number:
PCT/KR2018/011248
Publication Date:
May 02, 2019
Filing Date:
September 21, 2018
Export Citation:
Assignee:
CUROGENE LIFE SCIENCES CO LTD (KR)
Foreign References:
| US6093392A | 2000-07-25 |
Other References:
WONG WL ET AL., LANCET GLOB. HEALTH, vol. 2, 2014, pages el06
NOWAK J.Z., PHARMACOL. REP., vol. 58, 2006, pages 353
KENDALL, R.L.THOMAS, K.A., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 10705 - 10709
NEUMANN ET AL., EMBO J., vol. 1, 1982, pages 841
See also references of EP 3701972A4
NOWAK J.Z., PHARMACOL. REP., vol. 58, 2006, pages 353
KENDALL, R.L.THOMAS, K.A., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 10705 - 10709
NEUMANN ET AL., EMBO J., vol. 1, 1982, pages 841
See also references of EP 3701972A4
Attorney, Agent or Firm:
LEE, Cheo Young et al. (KR)
Download PDF: